How many institutions held RMTI - ROCKWELL MEDICAL, INC. - Common Stock, par value $0.0001 per share in Q1 2024?

31 institutional investors reported RMTI - ROCKWELL MEDICAL, INC. - Common Stock, par value $0.0001 per share for Q1 2024. Use the holders table for investor-level position and value details.

ROCKWELL MEDICAL, INC. - Common Stock, par value $0.0001 per share (RMTI)

Q: What does CUSIP 774374300 represent in this 13F holders report?

CUSIP 774374300 is the security identifier for RMTI - ROCKWELL MEDICAL, INC. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

CUSIP: 774374300

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 89,116,466
Total 13F shares: 5,445,105
Share change: +322,852
Total reported value: $9,038,469
Put/Call ratio: 226%
Price per share: $1.66
Number of holders: 31
Value change: +$463,006
Number of buys: 14
Number of sells: 14

Quarterly Holders Quick Answers

What is CUSIP 774374300?
CUSIP 774374300 identifies RMTI - ROCKWELL MEDICAL, INC. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2024
Previous quarter: Q4 2023

Recent filing periods for CUSIP 774374300:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RMTI - ROCKWELL MEDICAL, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ARMISTICE CAPITAL, LLC	13F	Company	2.1%	1,852,000	$3,500,280	—	31 Dec 2023	13F
VANGUARD GROUP INC	13F	Company	1.2%	1,074,975	$2,031,702	—	31 Dec 2023	13F
Richmond Brothers, Inc.	13F	Company	0.46%	412,433	$779,522	—	31 Dec 2023	13F
PERKINS CAPITAL MANAGEMENT INC	13F	Company	0.39%	349,934	$661,000	—	31 Dec 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.32%	283,923	$536,742	—	31 Dec 2023	13F
RAYMOND JAMES & ASSOCIATES	13F	Company	0.25%	220,979	$417,650	—	31 Dec 2023	13F
BlackRock Finance, Inc.	13F	Company	0.2%	178,201	$336,800	—	31 Dec 2023	13F
MARSHALL WACE, LLP	13F	Company	0.2%	175,096	$330,932	—	31 Dec 2023	13F
John Peter Mclaughlin	3/4/5	Director	— mixed-class rows	209,831 mixed-class rows	$191,764	—	17 Jun 2021	3/4/5
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.11%	98,200	$186,000	—	31 Dec 2023	13F
STATE STREET CORP	13F	Company	0.08%	74,304	$140,435	—	31 Dec 2023	13F
NORTHERN TRUST CORP	13F	Company	0.07%	63,838	$120,654	—	31 Dec 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.06%	49,632	$93,804	—	31 Dec 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.05%	47,733	$90,215	—	31 Dec 2023	13F
HighTower Advisors, LLC	13F	Company	0.04%	32,698	$62,000	—	31 Dec 2023	13F
JANE STREET GROUP, LLC	13F	Company	0.04%	32,279	$61,007	—	31 Dec 2023	13F
WealthTrust Axiom LLC	13F	Company	0.04%	31,500	$59,535	—	31 Dec 2023	13F
MORGAN STANLEY	13F	Company	0.03%	26,463	$50,015	—	31 Dec 2023	13F
Squarepoint Ops LLC	13F	Company	0.03%	24,522	$46,347	—	31 Dec 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.03%	23,841	$45,059	—	31 Dec 2023	13F
Paul E. McGarry	3/4/5	SVP, Finance and CAO	— mixed-class rows	65,725 mixed-class rows	$39,921	—	17 Mar 2023	3/4/5
Marc L. Hoffman	3/4/5	Chief Medical Officer	— mixed-class rows	58,655 mixed-class rows	$35,931	—	17 Mar 2023	3/4/5
GREAT VALLEY ADVISOR GROUP, INC.	13F	Company	0.02%	17,961	$33,946	—	31 Dec 2023	13F
SkyOak Wealth, LLC	13F	Company	0.02%	17,045	$32,215	—	31 Dec 2023	13F
Cetera Advisor Networks LLC	13F	Company	0.02%	14,127	$26,700	—	31 Dec 2023	13F
TRAPHAGEN INVESTMENT ADVISORS LLC	13F	Company	0.01%	11,100	$20,979	—	31 Dec 2023	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	3,211	$6,069	—	31 Dec 2023	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	2,687	$5,078	—	31 Dec 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	1,990	$3,761	—	31 Dec 2023	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	809	$1,529	—	31 Dec 2023	13F
Scarborough Advisors, LLC	13F	Company	0%	269	$508	—	31 Dec 2023	13F
Rise Advisors, LLC	13F	Company	0%	215	$406	—	31 Dec 2023	13F
COMERICA BANK	13F	Company	0%	163	$308	—	31 Dec 2023	13F
UBS Group AG	13F	Company	0%	90	$170	—	31 Dec 2023	13F
JPMORGAN CHASE & CO	13F	Company	0%	35	$66	—	31 Dec 2023	13F
Russell H. Ellison	3/4/5	President and Chief Executive Officer, Director	— class O/S missing	200,000	—	—	03 May 2021	3/4/5
Raymond Dennis Pratt	3/4/5	Chief Development Officer	— class O/S missing	112,500	—	—	03 May 2021	3/4/5
Russell Skibsted	3/4/5	EVP, Chief Financial Officer and Chief Business Officer	— class O/S missing	80,000	—	—	09 Sep 2022	3/4/5

Institutional Holders of ROCKWELL MEDICAL, INC. - Common Stock, par value $0.0001 per share (RMTI) as of Q1 2024

As of 31 Mar 2024, ROCKWELL MEDICAL, INC. - Common Stock, par value $0.0001 per share (RMTI) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,445,105 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, PERKINS CAPITAL MANAGEMENT INC, Richmond Brothers, Inc., GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., MARSHALL WACE, LLP, STATE STREET CORP, NORTHERN TRUST CORP, and CITADEL ADVISORS LLC. This page lists 31 institutional shareholders reporting positions in this security for the Q1 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders

Q1 2024 holders

Holder diff

-1

Investor	Q4 2023 Shares	Q1 2024 Shares	Share Diff	Share Chg %	Q4 2023 Value $	Q1 2024 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.